A phase II study of biweekly carboplatin (Cb) and gemcitabine (G) with bevacizumab (B) as first-line treatment in patients with advanced, inoperable stage IIIb/IV non-squamous non-small cell lung cancer (NSCLC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. e18091-e18091
Author(s):  
S. Bommakanti ◽  
T. Larson ◽  
A. Dudek ◽  
J. Koopmeiners ◽  
P. Kumar
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7073-7073 ◽  
Author(s):  
G. Giaccone ◽  
T. Lechevalier ◽  
N. Thatcher ◽  
E. Smit ◽  
M. Janmaat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

1997 ◽  
Vol 33 ◽  
pp. S236 ◽  
Author(s):  
N. Androulakis ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
A.M. Dimopoulos ◽  
E. Papadakis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document